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Primary angiosarcoma of the pericardium:
case report and review of the literature
Pierwotny mięsak naczyniowy osierdzia: opis przypadku i przegląd piśmiennictwa
Ana Teresa Timóteo, Luísa Moura Branco, Ivan Bravio, Eugénia Pinto, Teresa Timoteo,
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A b s t r a c t
Primary cardiac tumours are rare entities and angiosarcoma is the most frequent primary cardiac malignant tumour. Mean
survival is six months and the tumour responds poorly to chemotherapy. We present the case of a 50 year-old patient with
localised pericardial angiosarcoma who survived 23 months after diagnosis with a combined approach of chemotherapy and
surgery.
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INTRODUCTION
Primary cardiac tumours are rare entities and angiosarcoma
is the most frequent primary malignant cardiac tumour [1, 2].
The mean survival is six to eleven months and the tumour
responds poorly to chemotherapy [3, 4].
CASE REPORT
A 50 year-old female was referred to our institution for evalu-
ation of pericardial effusion. She complained of persistent pre-
cordial pain with onset five months before admission with pro-
gressive development of dyspnea, fatigue, ankle oedema and
increase in abdominal volume in subsequent months. A chest-X
ray, electrocardiogram and routine laboratory studies were
normal. A transthoracic echocardiogram (TTE) showed a mo-
derate-sized pericardial effusion. Later on, the patient develo-
ped tamponade and pericardiocentesis yield 700 mL of he-
morrhagic fluid. Cytological and bacteriological tests of the flu-
id were negative. The patient was treated for presumed viral
pericarditis. Follow-up TTE showed residual small pericardial
effusion next to the right atrium, with an echodense image that
was considered a residual organized hematoma. Two months
after drainage, symptoms recurred. At that time, TTE also
showed a bright echodensity in the right atrium posterior wall
(35 ¥ 33 mm) and adjacent pericardial space, with another extrin-
sic mass outside left atrium (24 ¥ 31 mm), confirmed by transe-
sophageal echocardiography. The first mass was in the pericar-
dial sac between the right atrium and left atrium, extending
into the right atrium (Fig. 1). A thoracic computed tomography
(CT)-scan done in the meantime showed diffuse thickening of
the pericardial membrane and pathological lymph nodes in the
superior and anterior mediastinum. The patient was again ad-
mitted for evaluation. Laboratory studies showed an increase
in erythrocyte sedimentation rate (ESR), as well as slight nor-
mocytic normocromic anaemia. The electrocardiogram sho-
wed sinus tachycardia and negative T waves in the anterior
and lateral leads. Abdominal and kidney ultrasound was nor-
mal. Cardiac magnetic resonance imaging (MRI) confirmed
diffuse thickening of the pericardium with moderate to large
pericardial effusion that caused constriction, with a haematic
and solid component. There was a mass in the top of right
atrium, which invaded the wall as well as the superior media-
stinum (namely superior vena cava) (Fig. 2, 3). The left atrium
extrinsic mass was interpreted as a blood collection that com-
pressed right lower pulmonary vein.
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The clinical condition of the patient deteriorated quickly
and mediastinoscopy was performed with pericardiocente-
sis, without significant removal of pericardial fluid, but with
pericardial and lymph node biopsy. Pathological examina-
tion revealed a papillary neoplasia composed of pleomorphic
spindle cells arranged as interconnecting vascular spaces. Im-
munohistochemical staining was positive for Vimentin and
CD31, confirming vascular differentiation and supporting the
diagnosis of poorly differentiated angiosarcoma (Fig. 4). Lymph
node biopsy showed only reactive inflammation. No other
localization was found for angiosarcoma. The patient was
transferred to the Oncology Department, where chemothe-
rapy was started with Ifosfamide 5 g/m2 day 1, Epirrubicine
50 mg/m2 day 1, Mesna 5 g/m2 day 1 and 2.5 mg/m2 day 2,
every 3 weeks (nine cycles: cumulative dose of epirrubicine
540 mg/m2). At six-month follow up, the patient was symp-
tom-free with complete disappearance of pericardial effusion
and no residual mass in the right atrium. A few months later,
a small pericardial effusion and mass recurred, confirmed by
cardiac-MRI, although the patient remained with few symp-
toms (chest pain). Chemotherapy was restarted for more six
cycles (lipossomic doxorrubicine 30 mg/m2 day 1, instead of
epirrubicine). Positron emission tomography (PET)-scan exc-
luded disseminated disease and the patient decided to un-
Figure 1. A. Sub-costal view showing a mass inside the pericardium (with pericardial effusion) and extending to the right atrium
free wall and inside; B. Apical 4-chamber view showing the pericardial mass extending to the right atrium
Figure 2. MRI Proton Density (Double IR) showing an isointense
mass in right atrium wall, invading surrounding structures and
also pericardial effusion
Figure 3. MRI T2 FATSAT sequence, which shows the same
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derwent cardiac surgery at another institution. Intra-operati-
vely, there was a localized mass in the pericardium that did
not seem to invade the right atrial wall, so the tumour was
surgically removed “en bloc” as well as right atrial free wall
which was reconstructed using a pericardial patch. There was
however a new recurrent pericardial effusion detected at sur-
gery, that was positive for malignant cells in post-operative
pathological examination. In the first post-operative TTE (one
month later), moderate heterogeneous pericardial effusion was
present, mainly septated next to the right ventricular apex.
No mass was detected in the right atrium. In subsequent TTE,
pericardial effusion increased, without causing tamponade.
A new PET-scan showed images of neoplastic masses around the
heart. Chemotherapy was changed to Docetaxel 100 mg/m2
due to a decrease in cardiac function, with poor tolerance
and only slight improvement in pericardial effusion dimen-
sions. The patient died with multiorgan failure 30 months after
the first symptoms, 23 months after diagnosis and 13 months
after surgery.
DISCUSSION
Primary cardiac tumours are rare entities (0.0017–0.003% of
routine autopsy studies, 25% malignant) [1]. Angiosarcoma is
the most frequent primary malignant cardiac tumour (31% of
all the malignancies) [2]. They have a tendency to occur in
the 3rd – 5th decade and are more common in males [5].
Metastatic disease is very frequent at the time of diagnosis
(66–89%), mainly locally (mediastinal lymph nodes, lungs and
vertebra) [6]. In a retrospective analysis of 149 primary car-
diac tumours, those arising from the pericardium (80%) and
arising on the right side of the heart (43.5%) were usually
malignant [7]. Those originating from the posterior wall of the
right atrium increase the likelihood of a malignant process.
These tumours have a silent evolution for a long time, with
non-specific symptoms [8].
Primary cardiac tumours are often first detected by TTE
with pericardial effusion as in our case. Transesophageal echo-
cardiography delineates the tumour more accurately, namely
its location and characteristics [7]. Computed tomography and
MRI have excellent diagnostic advantages with regard to
tumour delineation, characterisation and spread [5]. In MRI,
T1 weighted or proton density (Double IR) images are iso or
hyperintense related to myocardium and T2 weighted are hy-
perintense. These characteristics were present in our case. MRI
also allowed a more precise definition of localisation, contour,
local spread and involvement of adjacent structures. When dra-
ined, the fluid is usually hemorrhagic and cytological analysis is
often negative for malignant cells as in our patient [9]. The main
location is in the right atrium (90%) and pericardial involve-
ment can cause pericardial constriction [9]. These tumours grow
rapidly with local invasion and distant metastasis. It is usually
a fungating pink-tan mass with vascular channels by endothe-
lial malignant differentiation [9]. It stains immunohistochemi-
cally positive for CD31, CD34 and Factor VIII, confirming va-
scular differentiation (CD31 in our patient) [9].
Mean survival is 6–11 months with some anecdotal ca-
ses up to two years and one case up to four years [3, 10].
Angiosarcoma responds poorly to chemotherapy [4]. Che-
motherapeutic drugs used to treat cardiac angiosarcoma inc-
lude adriamicin, ifosfamide, cyclophosfamide, vincristine or
dacarbazine [5]. Most oncologists use adriamicine-based re-
gimens. Results of surgical resection alone have been disco-
uraging because most patients have advanced disease with
a mean survival of nine months, depending on whether adju-
vant treatment with radiation and/or chemotherapy was gi-
ven [6]. Mean survival of patients with more localised masses,
with tumour resection (more than half received adjuvant che-
motherapy), is only ten months [6]. Orthotopic cardiac trans-
plantation has been carried out in some cases, but survival
did not differ from those without transplantation [11].
Our patient had a very impressive initial response to che-
motherapy during the first 6 months. However, the tumour
soon recurred. Although the lack of myocardial adhesions
and distant metastisation allowed surgical exeresis, and de-
spite prolonged intensive chemotherapy, the patient died
because of pericardial recurrence. This is one of the longest
survivals of a patient with cardiac angiosarcoma, in a patient
with a relatively localised tumour.
Figure 4. A, B. Papillary neoplasia composed of atypical endothelial cells (pleomorphic spindle cells) arranged as interconnecting
vascular spaces (HE); C. Immunohistochemistry with positive staining for CD31, confirming vascular differentiation
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